Alexandria Real Estate Equities, Inc. Celebrates Grand Opening of Adaptive Biotechnologies' New State-of-the-Art Waterfront Headquarters/R&D Facility at 1165 Eastlake in the Thriving Seattle Life Science Cluster
Shares of Adaptive Biotechnologies double in hot IPO | The Seattle Times
A Message from Co-Founder and CEO Chad Robins
Adaptive Leadership - Adaptive Biotech
Adaptive Immunosequencing - Adaptive Biotech
Who We Are - Adaptive Biotech
Microsoft invests in Adaptive Biotechnologies to develop blood test to detect diseases | The Seattle Times
Adaptive Biotechnologies and Microsoft expand partnership to decode COVID-19 immune response and provide open data access - Stories